Alpha Teknova (TKNO) Net Income Growth (3y) (2023 - 2026)
Alpha Teknova (TKNO) Net Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -17.90% |
| 10 | Alpha Teknova | 262.13 Mn | 244.35 Mn | 3.78 Mn | 19.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.76% |
| Dec 31, 2025 | 32.24% |
| Sep 30, 2025 | 42.32% |
| Jun 30, 2025 | 16.80% |
| Mar 31, 2025 | 5.22% |
| Dec 31, 2024 | 4.10% |
| Sep 30, 2024 | -32.62% |
| Jun 30, 2024 | -33.93% |
| Mar 31, 2024 | -131.22% |
| Dec 31, 2023 | -82.81% |
| Sep 30, 2023 | -105.06% |
| Jun 30, 2023 | -150.29% |